Concepedia
Statistics
Publications
28
Citations
1.7K
H-Index
19
Active since
1989
Affiliations
Gilead Sciences (United States)(Current)
W.E. Upjohn Institute for Employment Research
University of Arizona
Texas Biomedical Research Institute
Georgetown University
Grushenka H.I. Wolfgang is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and life sciences.
Publications per year
1989–2016
GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
Robert E. Lanford, Bernadette Guerra, Deborah Chavez et al. · Gastroenterology · 2013 · 371 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Éric Lefebvre, Graeme Moyle, Ran Reshef et al. · PLoS ONE · 2016 · 312 citations · Full text
Medicine, Immunology, Pharmacology +17
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Stephan Menne, Daniel B. Tumas, Katherine H. Liu et al. · Journal of Hepatology · 2015 · 203 citations · Full text
Life Sciences, Immunology, Pharmacology +17
GS-9219—A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non–Hodgkin's Lymphoma
Hans Reiser, Jianying Wang, Lee K. Chong et al. · Clinical Cancer Research · 2008 · 87 citations
Medicine, Oncology, Pharmacology +16
Predicting human safety: screening and computational approaches
Dale E Johnson, Grushenka H.I. Wolfgang · Drug Discovery Today · 2000 · 76 citations
Engineering, Systems Engineering, Hazard Identification +13
1–5 of 28